Early screening and staging of melanoma using blood based on laser-induced breakdown spectroscopy

Abstract

Listen

Translate article

For melanoma, early screening could increase the cure rate, while staging helps to make treatment strategies. Blood sampling has advantages of little damage, convenient operation and low cost, which combined with laser-induced breakdown spectroscopy (LIBS) has been utilized for tumor diagnoses. Here, we proposed to accurately attain early screening and staging of melanoma blood using LIBS. The serum was collected from 25 melanoma mice and 10 healthy controls on the 7th, 14th, 21st and 28th days. Compared with k nearest neighbor (kNN), support vector machine (SVM) and back propagation neural network (BPNN) models, the adaptive boosting of BPNN (BP_AdaBoost) models had the best accuracies of 83.37 % for early screening and 96.18 % for staging, respectively. Using mutual information (MI) method to select features, the accuracies of BP_AdaBoost models were improved to 86.11 % for early screening and 96.91 % for staging, respectively. Besides, the difference significance of elements and molecular bands in the serum was examined by the Kruskal-Wallis (K-W) test. The test results showed that obvious differences of Ca and Na existed in both early screening and staging, while K and Mg made significant differences in staging, consistent with roles of Ca and Na in the whole process of tumor development and roles of K and Mg in tumor proliferation and metastasis. Overall, all results demonstrated that early screening and staging of melanoma could be accurately realized using blood based on LIBS.